Law360 (November 24, 2020, 9:56 PM EST) -- An organization representing top pharmaceutical research firms and two health care advocacy groups have sued the Trump administration in D.C. federal court to block a new federal policy allowing states, tribes, pharmacists and wholesalers to import certain prescription drugs from Canada without approval from drug manufacturers.
The Pharmaceutical Research and Manufacturers of America, Partnership for Safe Medicines and Council for Affordable Health Coverage alleged in a suit Monday that the U.S. Food and Drugs Administration and Department of Health and Human Services exceeded their legal authority in promulgating the final rule this fall to allow imported drugs without manufacturers' authorization or oversight...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!